Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas.

Smith J, Reidy-Lagunes D.

Semin Oncol. 2013 Feb;40(1):100-8. doi: 10.1053/j.seminoncol.2012.11.011. Review.

PMID:
23391117
2.

The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas.

Strosberg JR, Coppola D, Klimstra DS, Phan AT, Kulke MH, Wiseman GA, Kvols LK; North American Neuroendocrine Tumor Society (NANETS).

Pancreas. 2010 Aug;39(6):799-800. doi: 10.1097/MPA.0b013e3181ebb56f.

3.

Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?

Shia J, Tang LH, Weiser MR, Brenner B, Adsay NV, Stelow EB, Saltz LB, Qin J, Landmann R, Leonard GD, Dhall D, Temple L, Guillem JG, Paty PB, Kelsen D, Wong WD, Klimstra DS.

Am J Surg Pathol. 2008 May;32(5):719-31. doi: 10.1097/PAS.0b013e318159371c.

PMID:
18360283
4.

Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.

Koumarianou A, Chatzellis E, Boutzios G, Tsavaris N, Kaltsas G.

Endokrynol Pol. 2013;64(1):60-72. Review.

PMID:
23450449
5.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
6.

Neuroendocrine carcinoma of unknown primary site.

Spigel DR, Hainsworth JD, Greco FA.

Semin Oncol. 2009 Feb;36(1):52-9. doi: 10.1053/j.seminoncol.2008.10.003. Review.

PMID:
19179188
7.

High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases.

Nassar H, Albores-Saavedra J, Klimstra DS.

Am J Surg Pathol. 2005 May;29(5):588-94.

PMID:
15832081
8.

Clinical features and outcomes of primary hepatic neuroendocrine carcinomas.

Park CH, Chung JW, Jang SJ, Chung MJ, Bang S, Park SW, Song SY, Chung JB, Park JY.

J Gastroenterol Hepatol. 2012 Aug;27(8):1306-11. doi: 10.1111/j.1440-1746.2012.07117.x.

PMID:
22414232
9.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
10.

[Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system].

Pellat A, Wislez M, Svrcek M, Hammel P, Afchain P, André T.

Bull Cancer. 2016 Oct;103(10):880-895. doi: 10.1016/j.bulcan.2016.06.006. Epub 2016 Aug 6. French.

PMID:
27507031
11.

Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues.

Volante M, Birocco N, Gatti G, Duregon E, Lorizzo K, Fazio N, Scagliotti GV, Papotti M.

Hum Pathol. 2014 Apr;45(4):665-73. doi: 10.1016/j.humpath.2013.03.016. Epub 2013 Jun 24. Review.

12.

Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.

Wang SC, Fidelman N, Nakakura EK.

Semin Oncol. 2013 Feb;40(1):69-74. doi: 10.1053/j.seminoncol.2012.11.007. Review.

PMID:
23391114
13.
14.

Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.

White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, Pappas T, Hurwitz H, Tyler D.

Ann Surg Oncol. 1999 Jan-Feb;6(1):38-45.

PMID:
10030414
15.

Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.

Iwasa S, Morizane C, Okusaka T, Ueno H, Ikeda M, Kondo S, Tanaka T, Nakachi K, Mitsunaga S, Kojima Y, Hagihara A, Hiraoka N.

Jpn J Clin Oncol. 2010 Apr;40(4):313-8. doi: 10.1093/jjco/hyp173. Epub 2010 Jan 4.

PMID:
20047862
16.

Patterns of failure following surgical resection for malignant pleural mesothelioma.

Jänne PA, Baldini EH.

Thorac Surg Clin. 2004 Nov;14(4):567-73. Review.

PMID:
15559064
17.

Treatment policy of neuroendocrine small cell cancer of the cervix.

Trinh XB, Bogers JJ, Van Marck EA, Tjalma WA.

Eur J Gynaecol Oncol. 2004;25(1):40-4. Review.

PMID:
15053060
18.

Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.

Veras E, Deavers MT, Silva EG, Malpica A.

Am J Surg Pathol. 2007 May;31(5):774-82.

PMID:
17460463
19.

Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas.

Volante M, Monica V, Birocco N, Brizzi MP, Busso S, Daniele L, La Rosa S, Righi L, Sapino A, Berruti A, Scagliotti GV, Papotti M.

Neuroendocrinology. 2015;101(2):151-60. doi: 10.1159/000375449. Epub 2015 Jan 29.

PMID:
25633872
20.

Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts.

Deodhar KK, Kerkar RA, Suryawanshi P, Menon H, Menon S.

J Cancer Res Ther. 2011 Apr-Jun;7(2):211-3. doi: 10.4103/0973-1482.82942.

Supplemental Content

Support Center